Multiblock Discriminant Analysis of Integrative 18F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy

Author:

Lee Sang HoORCID,Kao Gary D.,Feigenberg Steven J.,Dorsey Jay F.,Frick Melissa A.,Jean-Baptiste Samuel,Uche Chibueze Z.,Cengel Keith A.,Levin William P.,Berman Abigail T.,Aggarwal Charu,Fan Yong,Xiao Ying

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference59 articles.

1. Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study results;Dorsey;Cancer,2015

2. Circulating tumor cell as a diagnostic marker in primary lung cancer;Tanaka;Clin Cancer Res,2009

3. Circulating tumor cells in diagnosing lung cancer: Clinical and morphologic analysis;Fiorelli;Ann Thorac Surg,2015

4. Stereotactic ablative radiotherapy for early-stage lung cancer;Shah;Semin Radiat Oncol,2017

5. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The pattern of failure is distant;Bradley;Int J Radiat Oncol Biol Phys,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3